Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Cash from Financing Activities (2023 - 2025)

Cannabis Bioscience International Holdings' Cash from Financing Activities history spans 3 years, with the latest figure at $156716.0 for Q2 2025.

  • On a quarterly basis, Cash from Financing Activities fell 10.14% to $156716.0 in Q2 2025 year-over-year; TTM through May 2025 was $341824.0, a 27.46% decrease, with the full-year FY2025 number at $341824.0, down 27.46% from a year prior.
  • Cash from Financing Activities hit $156716.0 in Q2 2025 for Cannabis Bioscience International Holdings, up from $82358.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CBIH hit a ceiling of $216837.0 in Q4 2023 and a floor of $9534.0 in Q1 2024.
  • Historically, Cash from Financing Activities has averaged $118690.2 across 3 years, with a median of $119537.0 in 2025.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 95.3% in 2024 and later surged 763.83% in 2025.
  • Tracing CBIH's Cash from Financing Activities over 3 years: stood at $216837.0 in 2023, then tumbled by 66.74% to $72123.0 in 2024, then soared by 117.29% to $156716.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for CBIH at $156716.0 in Q2 2025, $82358.0 in Q1 2025, and $72123.0 in Q4 2024.